Top 10 Companies in the Healthcare Rigid Plastic Packaging Market (2026): Market Leaders Powering Global Healthcare

In Business Insights
June 27, 2026

MARKET INSIGHTS

The global healthcare rigid plastic packaging market size was valued at USD 8,584 million in 2025. The market is projected to grow from USD 9,136 million in 2026 to USD 13,270 million by 2034, exhibiting a compound annual growth rate (CAGR) of 6.5% during the forecast period.

Healthcare rigid plastic packaging refers to the use of inflexible plastic materials in packaging for healthcare products, such as pharmaceuticals, medical devices, diagnostics, and over-the-counter (OTC) items. This type of packaging is specifically engineered to provide a high barrier against moisture, oxygen, and other environmental contaminants, ensuring the sterility, integrity, and stability of sensitive medical products from manufacturing through to end‑use. Key material types include Polypropylene (PP), Polyethylene (PE), Polycarbonate (PC), Polystyrene (PS), and Polyvinyl Chloride (PVC).

The market growth is primarily driven by the rising global demand for pharmaceuticals and medical devices, alongside stringent regulatory requirements for product safety and sterility. The United States represents the largest single‑country market, while the Asia‑Pacific region, led by China, is anticipated to witness the fastest growth due to expanding healthcare infrastructure and manufacturing capabilities. The market is characterized by the presence of several key global players, including Amcor plc, Gerresheimer AG, and Berry Global, Inc., who compete on innovation, regulatory compliance, and the development of sustainable packaging solutions.

Healthcare Rigid Plastic Packaging Market – View in Detailed Research Report

1️⃣ Gerresheimer AG

Headquarters: Frankfurt, Germany
Key Offering: Pharmaceutical and medical device packaging solutions including vials, syringes, and blow‑fill‑seal components

Gerresheimer AG is a leading global provider of sterile packaging solutions, known for its extensive portfolio of high‑barrier PP and PC containers that meet stringent regulatory standards. With a strong presence in the EU and Asia, the company serves major pharma and biotech firms worldwide.

Sustainability Initiatives:

  • Investing in recycled PP content and reducing CO2 emissions
  • Developing biodegradable packaging for specific applications
  • Commitment to circular economy principles

2️⃣ Amcor plc

Headquarters: Zurich, Switzerland
Key Offering: Advanced flexible and rigid packaging solutions, including high‑barrier PP and PC bottles for pharmaceuticals

Amcor is a diversified packaging company that offers integrated solutions for drug delivery, including pre‑filled syringes and blister packs. Its expertise in material science enables it to deliver packaging that meets global regulatory requirements.

Sustainability Initiatives:

  • Leading in sustainable packaging with 100% recyclable materials
  • Aiming for zero waste to landfill
  • Investing in renewable energy across facilities

3️⃣ Berry Global, Inc.

Headquarters: Atlanta, Georgia
Key Offering: High‑performance rigid containers and closure systems for pharmaceuticals and medical devices

Berry Global provides a comprehensive portfolio of PP, PE, and PC containers that offer superior barrier properties and are engineered for sterilization and single‑use applications.

Sustainability Initiatives:

  • Investing in post‑consumer recycled content and reducing packaging weight
  • Developing lightweight, high‑barrier materials
  • Commitment to circular packaging solutions

4️⃣ Becton, Dickinson and Company (BD)

Headquarters: Franklin, Tennessee
Key Offering: Drug delivery devices and packaging components, including pre‑filled syringes and autoinjectors

BD is a global leader in medical technology, supplying integrated packaging solutions that ensure sterility and patient safety, especially for biologics and high‑potency drugs.

Sustainability Initiatives:

  • Developing eco‑friendly injection devices and packaging materials
  • Reducing single‑use plastic waste through design innovation
  • Investing in renewable energy and energy‑efficient manufacturing

5️⃣ West Pharmaceutical Services, Inc.

Headquarters: Deerfield, Illinois
Key Offering: Packaging components for injectable drugs, including syringes, auto‑injectors, and pre‑filled systems

West Pharmaceutical Services specializes in high‑quality, sterile packaging solutions that support the global distribution of injectable drugs and biologics.

Sustainability Initiatives:

  • Investing in recyclable packaging materials and energy‑efficient manufacturing
  • Reducing packaging weight and material usage
  • Commitment to sustainable supply chain practices

6️⃣ Schott AG

Headquarters: Mainz, Germany
Key Offering: Glass and plastic packaging solutions for pharmaceutical and biotech products

Schott AG provides high‑quality glass and rigid plastic containers with excellent barrier properties, used for high‑value drugs and biologics.

Sustainability Initiatives:

  • Focus on recyclable glass and sustainable PP blends
  • Reducing energy consumption in manufacturing
  • Commitment to circular economy principles

7️⃣ Silgan Holdings Inc.

Headquarters: Hialeah, Florida
Key Offering: Advanced packaging solutions for pharmaceuticals, including high‑barrier containers and closure systems

Silgan offers a range of rigid containers made from PP and PC, designed for sterility and long shelf‑life.

Sustainability Initiatives:

  • Emphasis on recyclable materials and reduced packaging weight
  • Investing in sustainable material development
  • Energy‑efficient manufacturing processes

8️⃣ Aptargroup, Inc.

Headquarters: Madison, Wisconsin
Key Offering: Medical device packaging components and drug delivery devices

Aptargroup provides specialized packaging solutions for medical devices, including injection devices and containers that meet stringent regulatory requirements.

Sustainability Initiatives:

  • Developing sustainable packaging materials and reducing environmental footprint
  • Investing in recyclable and biodegradable materials
  • Commitment to eco‑friendly manufacturing

9️⃣ Nemera Development S.A.

Headquarters: Le Chesnay, France
Key Offering: Drug delivery device components, including pre‑filled syringes and auto‑injectors

Nemera is a leading developer of drug delivery systems that integrate packaging and device functionality, ensuring precise dosing and sterility.

Sustainability Initiatives:

  • Lightweight, recyclable materials for delivery devices
  • Reducing single‑use plastic waste
  • Investing in sustainable material research

🔟 Sonoco Products Company

Headquarters: Charlotte, North Carolina
Key Offering: Rigid plastic packaging for pharmaceuticals, medical devices, and diagnostics

Sonoco provides a wide range of PP and PC containers that offer high barrier protection and are designed for sterilization and single‑use applications.

Sustainability Initiatives:

  • Investing in recycled content and energy‑efficient manufacturing
  • Reducing packaging weight and material usage
  • Commitment to circular economy and sustainability

Download FREE Sample Report

Get Full Report Here

Outlook: The Future of Healthcare Rigid Plastic Packaging

The healthcare rigid plastic packaging market is poised for sustained growth driven by increasing demand for pharmaceuticals, expanding healthcare infrastructure, and a strong focus on sustainability and smart packaging. Regulatory pressures from the FDA, EMA, and other global bodies continue to shape product development, while emerging technologies such as NFC tags, QR codes, and RFID integration are redefining patient adherence and supply‑chain visibility.

Key Trends Shaping the Market

  • Rapid expansion of high‑barrier materials and recyclable mono‑material solutions
  • Integration of smart packaging technologies for track‑and‑trace and patient engagement
  • Growing emphasis on sustainability, circular economy, and reduced plastic waste
  • Increasing adoption of digital solutions for supply‑chain transparency and counterfeit prevention
  • Continued innovation in drug delivery systems, particularly for biologics and high‑potency APIs